Skip to main content
TipRanks
Go Ultimate75% OFF

ICU Medical (IC7) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

ICU Medical has a market cap or net worth of EUR 4.07B. The enterprise value is EUR 4.94B.

Market Cap
EUR 4.07B
Enterprise Value
EUR 4.94B

Share Statistics

ICU Medical has 25,010,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
25,010,100
Owned by Insiders
1.77%
Owned by Institutions
96.53%

Financial Efficiency

ICU Medical’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.69%.

Return on Equity (ROE)
0.00
Return on Assets (ROA)
0.00
Return on Invested Capital (ROIC)
0.69%
Return on Capital Employed (ROCE)
0.03
Revenue Per Employee
171.54K
Profits Per Employee
56.308
Employee Count
13,000
Asset Turnover
0.55
Inventory Turnover
2.29

Valuation Ratios

The current PE Ratio of ICU Medical is 74.39. ICU Medical’s PEG ratio is 0.00.

PE Ratio
74.39
PS Ratio
2.05
PB Ratio
2.05
Price to FCF
21.49
Price to Operating Cash Flow
16.05
PEG Ratio
0.00

Income Statement

In the last 12 months, ICU Medical had revenue of 2.23B and earned 732.00K in profits. Earnings per share was 0.03.

Revenue
2.23B
Gross Profit
819.65M
Operating Income
106.95M
Pretax Income
3.17M
Net Income
732.00K
EBITDA
309.29M
Earnings Per Share (EPS)
0.03

Cash Flow

In the last 12 months, operating cash flow was 279.24M and capital expenditures -70.64M, giving a free cash flow of 208.60M billion.

Operating Cash Flow
279.24M
Free Cash Flow
208.60M
Free Cash Flow per Share
8.34

Dividends & Yields

ICU Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
4.65%
Earnings Yield
1.35%

Stock Price Statistics

Beta
0.53
52-Week Price Change
36.44%
50-Day Moving Average
143.74
200-Day Moving Average
128.92
Relative Strength Index (RSI)
65.11
Average Volume (3m)
40

Important Dates

ICU Medical upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Mar 03, 2027
Ex-Dividend Date
―

Financial Position

ICU Medical as a current ratio of 2.36, with Debt / Equity ratio of 65.55%

Current Ratio
2.36
Quick Ratio
1.13
Debt to Market Cap
0.38
Net Debt to EBITDA
3.51
Interest Coverage Ratio
1.01

Taxes

In the past 12 months, ICU Medical has paid 2.44M in taxes.

Income Tax
2.44M
Effective Tax Rate
0.77

Enterprise Valuation

ICU Medical EV to EBITDA ratio is 18.72, with an EV/FCF ratio of 25.57.

EV to Sales
2.44
EV to EBITDA
18.72
EV to Free Cash Flow
25.57
EV to Operating Cash Flow
19.10

Balance Sheet

ICU Medical has EUR 301.78M in cash and marketable securities with EUR 1.15B in debt, giving a net cash position of -EUR 850.07M billion.

Cash & Marketable Securities
EUR 301.78M
Total Debt
EUR 1.15B
Net Cash
-EUR 850.07M
Net Cash Per Share
-EUR 33.99
Tangible Book Value Per Share
EUR 6.88

Margins

Gross margin is 38.71%, with operating margin of 6.75%, and net profit margin of 2.76%.

Gross Margin
38.71%
Operating Margin
6.75%
Pretax Margin
1.67%
Net Profit Margin
2.76%
EBITDA Margin
13.05%
EBIT Margin
3.73%

Analyst Forecast

The average price target for ICU Medical is EUR 177.47, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 177.47
Price Target Upside
10.23% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
-10.78%
EPS Growth Forecast
―

Scores

Smart Score
6
AI Score
―